Skip to content
HowShorted

Co-Diagnostics, Inc. short interest in 2021

In 2021, Co-Diagnostics, Inc.'s disclosed short interest ran from 21.17% of shares outstanding on 15 Jan 2021 to 4.95% on 31 Dec 2021, a change of -16.22 percentage points. The year's high was 21.17% on 15 Jan 2021 and its low 4.37% on 15 Dec 2021, averaging 11.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.67 days on 15 Jul 2021. Full history: Co-Diagnostics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Co-Diagnostics, Inc. in 2021

2021 in figures

Start of year
21.17% (15 Jan 2021)
End of year
4.95% (31 Dec 2021)
Change
-16.22 pp
High
21.17% (15 Jan 2021)
Low
4.37% (15 Dec 2021)
Average
11.96%
Highest days to cover
8.67 (15 Jul 2021)
SEC filings marked
9

Every report in 2021

Co-Diagnostics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202121.17%4.84results (8-K)
29 Jan 202117.85%3.30
12 Feb 202117.66%2.11
26 Feb 202113.99%2.90
15 Mar 202114.47%3.71
31 Mar 202117.25%3.6710-K filed, results (8-K)
15 Apr 202114.82%5.21
30 Apr 202115.78%6.85
14 May 202116.98%7.0310-Q filed, results (8-K)
28 May 202116.91%7.51
15 Jun 202116.33%5.78
30 Jun 202112.63%3.43
15 Jul 202111.68%8.67
30 Jul 202110.53%1.12
13 Aug 202110.79%1.6610-Q filed, results (8-K)
31 Aug 20218.26%2.29
15 Sep 20217.70%3.53
30 Sep 20217.45%5.31
15 Oct 20217.22%5.19
29 Oct 20215.75%5.67
15 Nov 20217.64%3.4310-Q filed, results (8-K)
30 Nov 20214.83%2.09
15 Dec 20214.37%3.47
31 Dec 20214.95%1.17

See also: Co-Diagnostics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.